$ARIA News Six stocks to watch 3:27 p.m. Feb. 26, 2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2014 at 8:55 AM

$ARIA News

Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com

'Mad Money' Lightning Round: A Group to Avoid 6:00 a.m. Nov. 14, 2014 - TheStreet.com
Cramer's Lightning Round - Affymetrix Teased And Disappointed, But Is A Buy (11/13/14) 3:40 a.m. Nov. 14, 2014 - Seeking Alpha
10-Q: ARIAD PHARMACEUTICALS INC 4:53 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals 8:58 a.m. Nov. 6, 2014 - benzinga.com
Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2014 Results - Earnings Call Transcript 12:47 p.m. Nov. 5, 2014 - Seeking Alpha
Ariad updates guidance after Q3 results 9:49 a.m. Nov. 5, 2014 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Nov. 5, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. Nov. 4, 2014 - Seeking Alpha
Will ARIAD (ARIA) Miss This Earnings Season? - Analyst Blog 5:00 p.m. Nov. 4, 2014 - Zacks.com
CHMP says Iclusig OK to use as is, advises revised label 10:26 a.m. Oct. 24, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – NPSP ARIA ANAC CLDX 8:30 a.m. Oct. 20, 2014 - InvestorPlace.com
ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today 9:45 a.m. Oct. 16, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ARIA CLVS HZNP CBPO 1:00 p.m. Oct. 15, 2014 - InvestorPlace.com
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog 5:05 p.m. Oct. 14, 2014 - Zacks.com
Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog 5:55 p.m. Oct. 13, 2014 - Zacks.com
EMA's PRAC backs Iclusig 9:21 a.m. Oct. 10, 2014 - Seeking Alpha
ARIAD Gets Breakthrough Therapy Designation for AP26113 - Analyst Blog 5:49 p.m. Oct. 6, 2014 - Zacks.com
Ariad restructures license agreement with Bellicum 9:30 a.m. Oct. 6, 2014 - Seeking Alpha
Wayfair Rises, Westport Innovations Cuts Forecast 8:30 a.m. Oct. 6, 2014 - FOXBusiness
ARIAD Pharmaceuticals' All-In Bet On Europe 11:18 a.m. Oct. 5, 2014 - Seeking Alpha

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 9:44 a.m. Nov. 6, 2014 - BusinessWire - BZX
ARIAD Reports Third Quarter 2014 Financial Results and Development Progress 7:36 a.m. Nov. 5, 2014 - BusinessWire - BZX
ARIAD to Present at the Stifel 2014 Healthcare Conference 7:35 a.m. Nov. 4, 2014 - BusinessWire - BZX
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe 6:35 a.m. Oct. 24, 2014 - BusinessWire - BZX
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 7:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 7:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results 6:35 a.m. Oct. 15, 2014 - BusinessWire - BZX
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency 6:44 a.m. Oct. 10, 2014 - BusinessWire - BZX
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology 6:35 a.m. Oct. 6, 2014 - BusinessWire - BZX
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib 6:35 a.m. Oct. 2, 2014 - BusinessWire - BZX
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 6:35 a.m. Sept. 29, 2014 - BusinessWire - BZX
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE 11:41 a.m. Sept. 16, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 7:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress 10:34 p.m. Aug. 6, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel 6:36 a.m. Aug. 5, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 6:35 a.m. July 16, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avive Partners with Cambridge Fire for Lifesaving Training

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

NY Sheriffs' Court Battle: Immigration Policies Under Fire

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Feeding Families Foundation Gains $121,500 for NYC Push

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Citrine Finalizes Sale of Illinois Senior Living Asset

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Alcott HR's Sales Strategy Gets a Boost with New Hire

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Robotics in Cleaning: 2026 Sees Double Adoption Rates

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

RxWellness Hits Inc. 5000—Four Straight Wins Impress

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Paula's Choice Elevates Skincare Game with New Campaign

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Perk's U.S. Expansion: A Bold Move in Spend Control

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...